156 related articles for article (PubMed ID: 32311492)
1. Imine stilbene analog ameliorate isoproterenol-induced cardiac hypertrophy and hydrogen peroxide-induced apoptosis.
Raut GK; Manchineela S; Chakrabarti M; Bhukya CK; Naini R; Venkateshwari A; Reddy VD; Mendonza JJ; Suresh Y; Nallari P; Bhadra MP
Free Radic Biol Med; 2020 Jun; 153():80-88. PubMed ID: 32311492
[TBL] [Abstract][Full Text] [Related]
2. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
3. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
4. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
[TBL] [Abstract][Full Text] [Related]
5. Diazoxide Modulates Cardiac Hypertrophy by Targeting H2O2 Generation and Mitochondrial Superoxide Dismutase Activity.
Lucas AMB; de Lacerda Alexandre JV; Araújo MTS; David CEB; Ponte Viana YI; Coelho BN; Caldas FRL; Varela ALN; Kowaltowski AJ; Facundo HT
Curr Mol Pharmacol; 2020; 13(1):76-83. PubMed ID: 31340743
[TBL] [Abstract][Full Text] [Related]
6. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
7. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis.
Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J
Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004
[TBL] [Abstract][Full Text] [Related]
8. Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway.
Li Y; He B; Zhang C; He Y; Xia T; Zeng C
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986070
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna (Roxb.) on isoproterenol-induced cardiac hypertrophy in rats.
Kumar S; Jahangir Alam M; Prabhakar P; Ahmad S; Maulik SK; Sharma M; Goswami SK
J Ethnopharmacol; 2017 Feb; 198():98-108. PubMed ID: 28063919
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen (H
Zhang Y; Xu J; Long Z; Wang C; Wang L; Sun P; Li P; Wang T
Front Pharmacol; 2016; 7():392. PubMed ID: 27833552
[No Abstract] [Full Text] [Related]
11. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
Parreira RC; Gómez-Mendoza DP; de Jesus ICG; Lemos RP; Santos AK; Rezende CP; Figueiredo HCP; Pinto MCX; Kjeldsen F; Guatimosim S; Resende RR; Verano-Braga T
Proteomics Clin Appl; 2020 Jul; 14(4):e2000017. PubMed ID: 32506788
[TBL] [Abstract][Full Text] [Related]
13. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
[TBL] [Abstract][Full Text] [Related]
14. Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics.
Jiang X; Zhang K; Gao C; Ma W; Liu M; Guo X; Bao G; Han B; Hu H; Zhao Z
FASEB J; 2022 Dec; 36(12):e22672. PubMed ID: 36440960
[TBL] [Abstract][Full Text] [Related]
15. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking analysis of imine stilbene analogs and evaluation of their anti-aging activity using yeast and mammalian cell models.
Naini R; Chikati R; Vudem DR; Kancha RK
J Recept Signal Transduct Res; 2019 Feb; 39(1):55-59. PubMed ID: 31132911
[TBL] [Abstract][Full Text] [Related]
17.
Kumari S; Katare PB; Elancheran R; Nizami HL; Paramesha B; Arava S; Sarma PP; Kumar R; Mahajan D; Kumar Y; Devi R; Banerjee SK
Oxid Med Cell Longev; 2020; 2020():7147498. PubMed ID: 32082481
[No Abstract] [Full Text] [Related]
18. Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.
Sun S; Li T; Jin L; Piao ZH; Liu B; Ryu Y; Choi SY; Kim GR; Jeong JE; Wi AJ; Lee SJ; Kee HJ; Jeong MH
Am J Chin Med; 2018; 46(5):1021-1044. PubMed ID: 29986596
[TBL] [Abstract][Full Text] [Related]
19. Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
Liu H; Zhou Z; Deng H; Tian Z; Wu Z; Liu X; Ren Z; Jiang Z
Eur J Pharmacol; 2023 Jun; 949():175735. PubMed ID: 37080331
[TBL] [Abstract][Full Text] [Related]
20. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
